โ† Home
Home โ€บ Features
Features

India faces tariff threat as US Senate advances Russia sanctions bill

๐Ÿ“… 2026-07-29 ๐Ÿ“‚ Features
India faces tariff threat as US Senate advances Russia sanctions bill
Representative image ยท Pexels (free license)
Key points

US Senate vote triggers tariff threat for India

This week, the United States Senate voted to advance a bill that could impose tariffs of up to 100% on goods from countries that trade with Russia. India is among the nations most exposed to this measure. The bill, which targets what Washington calls 'enabling' of Russia's war economy, now moves to further debate and a final vote.

The legislation reflects a hardening bipartisan consensus in Washington. Lawmakers from both parties argue that countries like India must choose between doing business with the West or with a sanctioned Russia. For New Delhi, the choice is not that simple.

How we got here: India-Russia ties and US pressure

India and Russia have been strategic partners for decades. During the Cold War, Moscow was New Delhi's most reliable ally, supplying arms, technology, and diplomatic cover at the United Nations. That relationship never fully dissolved after 1991.

When Russia invaded Ukraine in February 2022, the US and Europe imposed sweeping sanctions. India refused to join the Western-led condemnation. Instead, it ramped up purchases of discounted Russian crude oil. By 2024, Russia had become India's top oil supplier, displacing traditional partners like Iraq and Saudi Arabia.

Washington repeatedly warned New Delhi against deepening energy ties with Moscow. US Treasury officials visited India, and diplomatic cables stressed the risk of 'secondary sanctions'. India argued that buying Russian oil was a matter of energy security, not geopolitics. It pointed out that European nations continued to buy Russian gas through pipelines.

The current bill is the strongest legislative response yet. It targets not just Russia but any country that the US determines is 'significantly' supporting Russia's military-industrial base. India's oil purchases, along with its growing trade in sensitive technology, place it squarely in the crosshairs.

Key players and their positions

The bill's chief sponsors in the Senate include Republican and Democratic hawks. Senator James Risch, the ranking Republican on the Foreign Relations Committee, has been a vocal critic of India's Russia policy. On the Democratic side, Senator Ben Cardin has called for 'consequences' for nations that help Moscow evade sanctions.

The Biden administration has taken a more calibrated approach. While it has sanctioned some Russian entities and individuals, it has so far held off on punishing India directly. The White House has not publicly endorsed or opposed the Senate bill, but officials have signalled concern over its broad scope.

In New Delhi, the government of Prime Minister Narendra Modi has maintained a balancing act. Modi has met both President Joe Biden and President Vladimir Putin in recent months. India continues to buy Russian oil, but it has also deepened defence and technology ties with the US. The Indian foreign ministry has not issued a formal statement on the Senate vote, but diplomatic sources say New Delhi is 'closely monitoring' developments.

Opposition parties in India have seized on the issue. Some have accused the Modi government of 'strategic drift', arguing that India's dependence on Russian oil has made it vulnerable to US pressure. Others have warned that the tariffs could hurt Indian exporters, particularly in sectors like pharmaceuticals, textiles, and engineering goods.

Timeline of a brewing crisis

What it means for ordinary Indians

If the bill becomes law, the most immediate impact will be on prices. A 100% tariff on Indian goods entering the US market would make products like generic medicines, auto parts, textiles, and software services significantly more expensive for American consumers. For Indian exporters, it could mean a sharp drop in orders.

India's pharmaceutical industry is particularly vulnerable. The US is the largest market for Indian generic drugs. A 100% tariff would either wipe out profit margins or force price hikes that could reduce demand. Industry bodies have already begun lobbying the government to intervene.

Small and medium exporters in Gujarat, Tamil Nadu, and Maharashtra could be hit hardest. These firms often operate on thin margins and lack the capacity to pivot quickly to alternative markets. Job losses in export-dependent sectors are a real risk.

At the macroeconomic level, the tariffs could widen India's trade deficit and put pressure on the rupee. The Reserve Bank of India may have to intervene more aggressively to stabilise the currency. Inflation, already a concern, could get a fresh jolt if the cost of imported inputs rises.

On the flip side, the crisis could accelerate India's push for self-reliance. The 'Make in India' programme, which has had mixed results, may get renewed urgency. Some analysts argue that the threat of US tariffs could force New Delhi to diversify its export markets and deepen trade ties with the European Union, Southeast Asia, and the Gulf.

What happens next

The bill still needs a final vote in the Senate and then approval in the House of Representatives. Both chambers are under Republican control, but the measure has significant bipartisan support. Passage is likely, though the exact tariff rates and the list of targeted countries could change during negotiations.

India's best hope lies in diplomacy. The Modi government has already begun reaching out to key US lawmakers and administration officials. The message is simple: India is a strategic partner, not an adversary. New Delhi may offer concessions, such as capping Russian oil imports or tightening export controls on sensitive technology.

But the window for a deal is narrowing. If the bill becomes law, India will have to decide whether to risk a trade war with its largest export market or sever a decades-old relationship with Moscow. Either choice will come with a heavy price.

Verify this story
Reported by TIVRA News Features Desk. This article was written with AI assistance from publicly available reporting โ€” always cross-check important details with the original coverage.
This content is AI-assisted and published for information only. TIVRA News links every story to its original source above โ€” please verify dates, figures and statements there. See our Disclaimer and Editorial Policy.